Penn Medicine Provider
Neurology
Michael Gelfand, MD, PhD
He/Him
4.9
(182)
Accepting new patients
Sees patients age 16 and up
Penn Neurology Pennsylvania Hospital
View 1 additional location

About me

  • Associate Professor of Clinical Neurology

Education and training

  • Medical School: NewYork-Presbyterian / Weill Cornell Medical Center
  • Residency: Mount Sinai Morningside
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

182 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
good doctor.
April 2025
5.0
5.0
he throughly explained everything in detail. that gave me comfort.
April 2025
5.0
5.0
he is an amazing physician
March 2025
5.0
5.0
the dr. is a very concerned & understanding

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Gelfand is a Penn Medicine physician.

Qualifications and experience

My research

Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events , JAMA Neurol, 81: 2024,835-844


Emmert BE, Xie K, Conrad EC, Ghosn NJ, Bauman K, Korzun J, Kulick-Soper CV, Naveed O, Hartmann N, LaRocque JJ, Mindy Ganguly T, Gugger JJ, Raghupathi R, Gelfand MA, Davis KA, Sinha SR, Litt B, Shinohara RT, Ellis CA. Alcohol for seizure induction in the epilepsy monitoring unit , Epilepsy Behav: 2024


Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE. Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations , Clin Pharmacol Ther: 2024


Zhou DJ, Woodson-Smith S, Emmert BE, Kornspun A, Larocque J, Kulick-Soper CV, Qiu MK, Ellis CA, Gugger JJ, Conrad EC, Waldman G, Ganguly T, Sinha SR, Davis KA, Stein JM, Liu GT, Gelfand M, Raghupathi R. Clinical characteristics and surgical outcomes of epilepsy associated with temporal encephalocele: A systematic review , Epilepsy Behav: 2024


French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group. Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial , JAMA Neurol, 80: 2023,1145-1154


Bases B, Barnard S, French JA, Pellinen J; Human Epilepsy Project. Impact of Seizures While Driving Prior to Diagnosis in People With Focal Epilepsy: Motor Vehicle Accidents and Time to Diagnosis , Neurology, 101: 2023,e1370-e1375


Kanner AM, Saporta AS, Kim DH, Barry JJ, Altalib H, Omotola H, Jette N, O'Brien TJ, Nadkarni S, Winawer MR, Sperling M, French JA, Abou-Khalil B, Alldredge B, Bebin M, Cascino GD, Cole AJ, Cook MJ, Detyniecki K, Devinsky O, Dlugos D, Faught E, Ficker D, Fields M, Gidal B, Gelfand M, Glynn S, Halford JJ, Haut S, Hegde M, Holmes MG, Kalviainen R, Kang J, Klein P, Knowlton RC, Krishnamurthy K, Kuzniecky R, Kwan P, Lowenstein DH, Marcuse L, Meador KJ, Mintzer S, Pardoe HR, Park K, Penovich P, Singh RK, Somerville E, Szabo CA, Szaflarski JP, Lin Thio KL, Trinka E, Burneo JG; Human Epilepsy Project. Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity , Neurology, 100: 2023,e1123-e1134


French J, Biton V, Dave H, Detyniecki K, Gelfand MA, Gong H, Liow K, O'Brien TJ, Sadek A, DiVentura B, Reich B, Isojarvi J. A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using StaccatoĀ® alprazolam for rapid seizure termination , Epilepsia: 2023


Pellinen J, Pardoe H, Sillau S, Barnard S, French J, Knowlton R, Lowenstein D, Cascino GD, Glynn S, Jackson G, Szaflarski J, Morrison C, Meador KJ, Kuzniecky R; Human Epilepsy Project Investigators. Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project , Epilepsia: 2023


Hina Dave, MD - UT Southwestern Medical Center; Jacqueline French, MD - NYU Comprehensive Epilepsy Center; Hamada Hamid Altalib, DO, MPH, FAES - Yale University; Heidi Henninger, MD - Maine Medical Center; Roger Porter, MD, ScD - Perelman School of Medicine, University of Pennsylvania; Michael Gelfand, MD, PhD - University of Pennsylvania; Melinda Martin, PhD - UCB Pharma, Smyrna; Prashant Dongre, MD - UCB Pharma, Smyrna; Sami Elmoufti, MS - UCB Pharma, Raleigh; Anne-Liv Schulz, MD - UCB Pharma, Monheim am Rhein; Michael Sperling, MD - Thomas Jefferson University Real-World Study of Brivaracetam in the United States , American Epilepsy Society: 2021